Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6248791

Stimulating the differentiation of preadipocytic cells and therapies based thereon

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248788

Therapeutic method with capsaicin and capasicin analogs

The Regents of the University of California · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248778

Anticholestatic effect of luteolin

Serturner Arzneimittel GmbH · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248749

Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acu

expired patent

US 6248740

Condensed pyridazine derivatives, their production and use

Takeda Chemical Industries Ltd. · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248528

Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

The Regents of the University of California · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248357

Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubilit

Takeda Chemical Industries Ltd. · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248351

Human PEA3 is a tumor suppressor for cancer cells

The Board of Regents of the University of Texas System · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245899

Composition for detection of cell density signal molecule

The Regents of the University of California · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245892

Invaplex from gram negative bacteria, method of purification and methods of use

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245752

Compositions and methods for tolerization in immune complex-mediated disease progression

BioCrystal, Ltd. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245747

Targeted site specific antisense oligodeoxynucleotide delivery method

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245743

Inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245737

Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245563

Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxi

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245561

.beta.-alethine use in cell culture and therapy

The Regents of the University of New Mexico · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245560

Vector with multiple target response elements affecting gene expression

expired patent

US 6245512

Promoter for VEGF receptor

The Regents of the University of California · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245362

Medication for treatment of viral disease based on active agents of plant hypericum (St. J

Dreluso Pharmazeutika Dr. Elten & Sohn GmbH · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245351

Controlled-release composition

Takeda Chemical Industries Ltd. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242488

Method for preventing and treating pain

The Regents of the University of Oklahoma · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242486

Long chain carboxybetaines in antimicrobial formulations

Integrated Research Technology, LLC · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242482

Prostaglandin compounds and derivatives thereof, compositions containing the same and meth

United Therapeutics Corporation · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242473

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired